Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
-
MDM2 inhibitor therapy for TP53 wild-type GBM
Sarkaria, J. N. (PI) & Sarkaria, J. J. N. (PI)
9/1/21 → 8/31/26
Project: Research project
-
-
Optimizing EGFR inhibitor-based therapies in GBM
Sarkaria, J. N. (PI)
10/1/04 → 8/31/06
Project: Research project
-
Mayo Clinic Comprehensive Cancer Center Support Grant
Adjei, A. (CoPI), Alberts, S. R. (CoPI), Ames, M. M. (CoPI), Beebe, T. J. (CoPI), Buckner, J. C. (CoPI), Chute, C. G. (CoPI), Cunningham, J. M. (CoPI), Diasio, R. B. (CoPI), Federspiel, M. J. (CoPI), Grendahl, D. (CoPI), Highsmith, E. W. (CoPI), Jenkins, R. B. (CoPI), Leibson, P. J. (CoPI), Lingle, W. L. (CoPI), Mc Cormick, D. J. (CoPI), Prendergast, F. G. (CoPI), Raghavakaimal, S. (CoPI), Salisbury, J. L. (CoPI), Sargent, D. J. (CoPI), Van Deursen, J. (CoPI), Wettstein, P. J. (CoPI), Wieben, E. D. (CoPI), Banks, P. M. (CoPI), Burnham, N. R. (CoPI), Clapham, D. (CoPI), David, C. S. (CoPI), Dewald, G. W. (CoPI), Held, K. (CoPI), Ingle, J. N. (CoPI), Katzmann, J. A. (CoPI), Katzmann, J. A. (CoPI), Kline, B. (CoPI), Kovach, J. S. (CoPI), Liebson, P. (CoPI), Maihle, N. J. (CoPI), McCormick, D. J. (CoPI), McKean, D. J. (CoPI), Moertel, C. G. (CoPI), O'Connell, M. J. (CoPI), O'Fallon, J. R. (CoPI), Prendergast, F. G. (CoPI), Roche, P. C. (CoPI), Spelsburg, T. C. (CoPI), Thibodeau, S. N. (CoPI), Weiland, L. H. (CoPI), Wieand, H. S. (CoPI), Wiebeu, E. D. (CoPI), Wold, L. (CoPI), Willman, C. (PI), Ames, M. (CoPI), Anastasiadis, P. Z. (CoPI), Ansell, S. M. (CoPI), Degnim, A. A. C. (CoPI), Baker, D. J. (CoPI), Bekaii-Saab, T. (CoPI), Borad, M. J. (CoPI), Horazdovsky, B. B. F. (CoPI), Cerhan, J. R. (CoPI), Cicek, M. (CoPI), Colon-Otero, G. (CoPI), Dispenzieri, A. (CoPI), Doubeni, C. C. A. (CoPI), Dueck, A. C. (CoPI), Finnes, H. D. (CoPI), Flotte, T. J. (CoPI), Odedina, F. F. T. (CoPI), Fonseca, R. (CoPI), Galanis, E. (CoPI), Goetz, M. P. (CoPI), Greipp, P. T. (CoPI), Nowakowski, G. G. S. (CoPI), Highsmith, W. E. (CoPI), Jatoi, A. (CoPI), Summer Bolster, J. J. (CoPI), Villasboas, J. J. C. (CoPI), Knutson, K. L. (CoPI), Kocher, J.-P. (CoPI), Kumar, S. K. (CoPI), Kwon, E. D. (CoPI), Ballman, K. K. V. (CoPI), Van Abel, K. K. (CoPI), Loprinzi, C. L. (CoPI), Rutten, L. L. J. (CoPI), Sherman, M. E. (CoPI), Mc Niven, M. A. (CoPI), O'connell, M. M. J. (CoPI), Lawson, M. M. A. (CoPI), Okuno, S. H. (CoPI), Pandey, A. (CoPI), Pease, L. R. (CoPI), Pitot, H. C. (CoPI), Pitot, J. ,. H. C. (CoPI), Radecki Breitkopf, C. (CoPI), Reid, J. M. (CoPI), Weinshilboum, R. M. (CoPI), Sarkaria, J. N. (CoPI), Kaufmann, S. S. H. (CoPI), Murphy, S. S. J. (CoPI), Vile, R. G. (CoPI), Welter, J. C. (CoPI) & Yost, K. J. (CoPI)
3/1/85 → 2/28/26
Project: Research project
-
A precision medicine umbrella trial to nominate promising therapies for glioblastoma
Sarkaria, J. N., Jan 1 2026, In: Neuro-oncology. 28, 1, p. 3-4 2 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Digital twins for in vivo metabolic flux estimations in patients with brain cancer
Meghdadi, B., Al-Holou, W. N., Scott, A. J., Mittal, A., Liang, N., Sravya, P., Achreja, A., O’Brien, A., Do, K., Wu, Z., Feng, J., Qi, N. R., Tarnal, V., Venneti, S., Miller, C. R., Sarkaria, J. N., Zhou, W., Lawrence, T. S., Lyssiotis, C. A. & Wahl, D. R. & 1 others, , Jan 6 2026, In: Cell Metabolism. 38, 1, p. 228-246.e17Research output: Contribution to journal › Article › peer-review
Open Access -
Drug and single-cell gene expression integration identifies sensitive and resistant glioblastoma cell populations
Suter, R. K., Jermakowicz, A. M., Veeramachaneni, R., D’Antuono, M., Zhang, L., Chowdary, R., Kaeppeli, S., Sharp, M., Palwai, P., Stathias, V., Baker, G., Ruiz, L., Walters, W., Cepero, M., Burgenske, D., Reilly, E. B., Oleksijew, A., Anderson, M. G., Williams, S. L. & Ivan, M. E. & 8 others, , Dec 2026, In: Nature communications. 17, 1, 99.Research output: Contribution to journal › Article › peer-review
Open Access -
Pharmacokinetic-pharmacodynamic-efficacy modeling of the MDM2 inhibitor brigimadlin in glioblastoma patient-derived xenografts
Vaubel, R. A., Zhang, W., Karbhari, N., Oh, J. H., Waller, K. L., Mladek, A., Jain, S., Burgenske, D. M., Decker, P. A., Kosel, M. L., Hu, Z., Ott, L. L., Carlson, B. L., Bakken, K. K., Pasa, T., Sarkaria, N. R., Talele, S., Eckel-Passow, J. E., Sini, P. & Elmquist, W. F. & 1 others, , Jan 1 2026, In: Neuro-Oncology Advances. 8, 1Research output: Contribution to journal › Article › peer-review
Open Access -
Reflecting on scientific growth and innovation as the Society for Neuro-Oncology turns 30
De la Fuente, M. I., Brastianos, P. K., Gampel, B., Nassiri, F., Raleigh, D. R., Ida, C. M., Abdelbaki, M. S., Pekmezci, M., Bagley, S., Young, J. S., Lukas, R. V., Hirbe, A. C., Ellingson, B. M., Villanueva-Meyer, J., Lasorella, A., Sarkaria, J. N., Gutmann, D. H., Haas-Kogan, D., Galanis, E. & Chang, S. M., Jan 1 2026, In: Neuro-oncology. 28, 1, p. 7-18 12 p.Research output: Contribution to journal › Review article › peer-review
Open Access